|
IRZSMU >
Кафедри >
Кафедра технології ліків >
Наукові праці. (Технологія ліків) >
Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на этот ресурс:
http://dspace.zsmu.edu.ua/handle/123456789/22696
|
Название: | Database analysis of completed clinical trials investigating hemostatic agents: implications for military trauma care |
Авторы: | Antypenko, L. Maletsky, M. M. Lysianska, H. P. Brytanova, T. S. Малецький, Микола Миколайович Лисянська, Ганна Петрівна Британова, Тетяна Сергіївна |
Ключевые слова: | clinical trials evidence-based medicine hemostatic agents military medicine war-related trauma |
Дата публикации: | 2025 |
Библиографическое описание: | Database analysis of completed clinical trials investigating hemostatic agents: implications for military trauma care / L. Antypenko, M. Maletsky, H. Lysianska, T. Brytanova // Science and technology: challenges, prospects and innovations : Proc. of 10th Intern. Sci. and Practical Conf. Osaka, Japan, May 22-24, 2025. - Osaka : CPN Publishing Group, 2025. - P. 207-217. |
Аннотация: | Annotation. This database analysis examined 365 completed clinical trials investigating hemostatic agents retrieved from ClinicalTrials.gov to characterize evidence for military trauma applications. Investigation revealed substantial clinical research activity with 183 studies addressing bleeding control and 148 studies involving surgical applications. Tranexamic acid emerged as the most extensively studied intervention with 49 trials encompassing 10,526 participants, followed by topical hemostatic matrices including TachoSil (11 studies, 5,095 participants), Floseal (13 studies, 1,845 participants), and Surgicel (12 studies, 1,400 participants). Topical matrices and sealants (58 studies, 15.9%) were identified as the predominant category, followed by antifibrinolytic agents (50 studies, 13.7%). Geographic distribution demonstrated United States leadership with 110 studies (30.1%) across 47 participating countries. Critical assessment revealed only one study conducted in military settings. This represents a fundamental disconnection between civilian
clinical validation and battlefield operational requirements. The absence of battlefield-validated protocols and austere environment testing constitutes critical limitations in evidence translation to combat casualty care. Future research priorities must emphasize studies conducted under combat-relevant conditions to bridge the civilian-military evidence gap. |
URI: | http://dspace.zsmu.edu.ua/handle/123456789/22696 |
Располагается в коллекциях: | Наукові праці. (Фармацевтична хімія) Наукові праці. (Технологія ліків)
|
Все ресурсы в архиве электронных ресурсов защищены авторским правом, все права сохранены.
|